Logo Image

Cathy Eng, MD, FACP, The University of Texas MD Anderson Cancer Center

Articles by Cathy Eng, MD, FACP, The University of Texas MD Anderson Cancer Center

Second-Line Treatment of mCRC: Rechallenging Therapy

ByTanios S. Bekaii-Saab, MD, Mayo Clinic,Cathy Eng, MD, FACP, The University of Texas MD Anderson Cancer Center,Joleen Hubbard, MD, Mayo Clinic,Kanwal Raghav, MD, MBBS, The University of Texas MD Anderson Cancer Center,John H. Strickler, MD, Duke Cancer Institute

The role of molecular assays, including liquid biopsies, in providing information on resistance mechanisms in metastatic colorectal cancer and the impact of testing results on decisions for rechallenging with a previous therapy.

Latest Updated Articles